Global Exoskeleton Market by Body Part Covered, Mode of Operation, Form of Exoskeleton, Mobility, End Users and Geography : Industry Trends and Global Forecasts, 2023-2035

Description

The global exoskeleton market is projected to reach USD 20,000 million by 2035 growing at a CAGR of 23.1% during the forecast period 2023-2035.

From the past years, the healthcare system has faced an increasing burden from neurological disorders like multiple sclerosis and strokes, which have become more prevalent. According to the World Health Organization (WHO), approximately 1.8 million people worldwide are currently living with multiple sclerosis, and over 12.2 million individuals suffer from strokes each year. These numbers are expected to rise further due to the aging population.

Neurological disorders often result in muscle weakness, impacting mobility, whether it's in specific muscle groups (like hemiplegia, paraplegia, or quadriplegia) or throughout the entire body. Unfortunately, there is no cure for neuromotor impairment, but the use of assistive mobility devices such as wheelchairs, crutches, and walkers can enhance independence and comfort for patients. While these devices are widely used, they offer short-term relief rather than a transformative solution. Additionally, improper handling or prolonged use of these devices can lead to physical fatigue, discomfort, and injuries, ultimately reducing the patients' quality of life. In fact, it's reported that approximately 50% of manual wheelchair users experience shoulder injuries at some point in their lives.

Over time, exoskeletons have emerged as a partial alternative or complementary rehabilitation device, enabling individuals with spinal cord injuries and related conditions to walk more freely in hospitals and at home compared to traditional mobility options. A medical exoskeleton is a wearable electromechanical device designed to assist patients with mobility issues, whether they are partially or completely paralyzed, in regaining movement in their upper or lower extremities. By harnessing neuroplasticity, medical exoskeletons equipped with sensors, motors, actuators, power sources, and control strategies facilitate the recovery of fundamental movements and accelerate rehabilitation from injuries, such as acquired brain injury (ABI) or spinal cord injury (SCI). Beyond patients, healthcare providers such as nurses and surgeons also face various musculoskeletal disorders due to the physically demanding nature of their roles in the healthcare sector. Medical exoskeletons can assist caregivers in tasks such as lifting and moving patients, navigating obstacles, and standing for extended periods.

Outside the healthcare industry, exoskeleton technology is being used to enhance the performance of workers and prevent work-related accidents in a wide range of industries, including construction, logistics, vehicle manufacturing, aircraft production, shipyards, automotive and metal mechanics, foundries, aeronautics, maintenance, and other factory work. According to estimates from the International Labor Organization (ILO), over 2.3 million workers die each year due to work-related accidents or diseases. With such a significant number of accidents occurring annually, the adoption of industrial exoskeletons to assist workers in physically demanding tasks such as lifting heavy loads or performing overhead work has the potential to not only improve workplace safety but also increase employee retention, enhance productivity, and reduce costs.

Owing to the numerous advantages they offer, the adoption of exoskeleton devices is hindered by various factors, including cost barriers and a lack of awareness among potential users. To encourage broader acceptance, exoskeleton companies are directing their research and development efforts towards reducing the cost of exoskeletons. They are also incorporating advanced technologies such as cloud computing, deep learning, smart sensors, and artificial intelligence into their exoskeleton product offerings. As exoskeleton technology continues to advance and the cost of these devices decreases, and as stakeholders recognize the positive return on investment (ROI) associated with exoskeleton products due to their higher benefit-cost ratio, the adoption of this emerging technology is expected to increase across various industries. This, in turn, will drive the growth of the global exoskeleton market during the forecast period.

Key Market Segments:

Body Part Covered

Upper Extremity
Lower Extremity
Full Body

Mode of Operation

Powered
Passive
Hybrid

Form

Rigid
Soft

Mobility

Fixed / Supported
Mobile

End Users

Patients
Healthcare Providers
Industry Workers
Military Personnel
Others

Geography

North America
Europe
Asia-Pacific
Rest of the World

Research Coverage:

The report studies the exoskeleton market based on body part covered, mode of operation, form of exoskeleton, mobility, end users and geography
The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.
The report forecasts the revenue of market segments with respect to four major regions
It offers an insightful assessment of product competitiveness in the medical exoskeleton market, considering factors like supplier strength, product features, and end users.
The report features detailed profiles of key wearable exoskeleton companies, focusing on their establishment, size, location, leadership, financial performance (if available), product portfolio, recent developments, and future outlook.
Analysis of recent partnerships and collaborations related to medical exoskeletons, established since 2017.
The report delves into patents filed or granted for exoskeletons since 2016, considering patent types, application and publication years, geographical location, applicant type, publication time, CPC symbols, and leading patent holders, accompanied by a comprehensive patent benchmarking analysis.
It provides a strategic guide for emerging medical exoskeleton companies to gain a competitive edge through a blue ocean strategy, offering thirteen strategic tools to explore untapped market opportunities.

Key Benefits of Buying this Report:

The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with a pulse on the exoskeleton market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies:

Bionic Yantra
CYBERDYNE
Ekso Bionics
ExoAtlet
Fourier Intelligence
Gloreha
Guangzhou Yikang Medical Equipment
Hexar Humancare
Hocoma
MediTouch
Milebot Robotics

Myomo
Neofect
NextStep Robotics
Panasonic
ReWalk Robotics
Rex Bionics
Roam Robotics
Trexo Robotics
Tyromotion
U&O Technologies

Product Code: RA100462

1. PREFACE

1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
- 2.7.1. Demographics
- 2.7.2. Economic Factors
- 2.7.3. Government Regulations
- 2.7.4. Supply Chain
- 2.7.5. COVID Impact / Related Factors
- 2.7.6. Market Access
- 2.7.7. Healthcare Policies
- 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

3.1. Chapter Overview
3.2. Market Dynamics
- 3.2.1. Time Period
  - 3.2.1.1. Historical Trends
  - 3.2.1.2. Current and Forecasted Estimates
- 3.2.2. Currency Coverage
  - 3.2.2.1. Overview of Major Currencies Affecting the Market
  - 3.2.2.2. Impact of Currency Fluctuations on the Industry
- 3.2.3. Foreign Exchange Impact
  - 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
  - 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
- 3.2.4. Recession
  - 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
  - 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
- 3.2.5. Inflation
  - 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
  - 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

5.1. Chapter Overview
5.2. Overview of Exoskeleton
5.3. History of Exoskeleton
5.4. Classification of Exoskeleton
- 5.4.1. Based on Body Part Supported
- 5.4.2. Based on Form of Exoskeleton
- 5.4.3. Based on Mode of Operation
- 5.4.4 Based on Mobility
5.5. Applications of Exoskeleton
5.6. Features of Exoskeleton
5.7. Limitations of Exoskeleton
5.8. Future Perspectives

6. MEDICAL EXOSKELETON: MARKET LANDSCAPE

6.1. Chapter Overview
6.2. Medical Exoskeleton: Overall Market Landscape
- 6.2.1. Analysis by Status of Development
- 6.2.2. Analysis by Type of Body Part Covered
- 6.2.3. Analysis by Mode of Operation
- 6.2.4. Analysis by Type of Body Part Covered and Mode of Operation
- 6.2.5. Analysis by Form of Exoskeleton
- 6.2.6. Analysis by Mode of Operation and Form of Exoskeleton
- 6.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
- 6.2.8. Analysis by Device Mobility
- 6.2.9. Analysis by Mode of Operation and Device Mobility
- 6.2.10. Analysis by Form of Exoskeleton and Device Mobility
- 6.2.11. Analysis by Type of Body Part Covered and Device Mobility
- 6.2.12. Analysis by User-Machine Interface
- 6.2.13. Analysis by Type of Body Part Covered and User-Machine Interface
- 6.2.14. Analysis by Mode of Operation and User-Machine Interface
- 6.2.15. Analysis by Availability of Advanced Features
- 6.2.16. Analysis by End User
- 6.2.17. Analysis by Patient Age Group
- 6.2.18. Analysis by Exoskeleton Setting for Patients
- 6.2.19. Analysis by Breakthrough Designation
6.3. Medical Exoskeleton: Developer: Landscape
- 6.3.1. Analysis by Year of Establishment
- 6.3.2. Analysis by Company Size
- 6.3.3. Analysis by Location of Headquarters
- 6.3.4. Analysis by Company Size and Location of Headquarters
- 6.3.5. Analysis by Company Ownership
- 6.3.6. Analysis by Location of Headquarters and Company Ownership
- 6.3.7. Analysis by Additional Services Offered
- 6.3.8. Most Active Players: Analysis by Number of Medical Exoskeleton

7. NON-MEDICAL EXOSKELETON: MARKET LANDSCAPE

7.1. Chapter Overview
7.2. Non-Medical Exoskeleton: Overall Market Landscape
- 7.2.1. Analysis by Status of Development
- 7.2.2. Analysis by Type of Body Part Covered
- 7.2.3. Analysis by Body Part Supported
- 7.2.4. Analysis by Mode of Operation
- 7.2.5. Analysis by Form of Exoskeleton
- 7.2.6. Analysis by Type of Body Part Covered and Mode of Operation
- 7.2.7. Analysis by Type of Body Part Covered and Form of Exoskeleton
- 7.2.8. Analysis by Mode of Operation and Form of Exoskeleton
- 7.2.9. Analysis by Application Area
- 7.2.10. Analysis by Mode of Operation and Application Area
7.3. Non-Medical Exoskeleton: Developer Landscape
- 7.3.1. Analysis by Year of Establishment
- 7.3.2. Analysis by Company Size
- 7.3.3. Analysis by Company Size and Employee Count
- 7.3.4. Analysis by Location of Headquarters
- 7.3.5. Analysis by Company Size and Location of Headquarters
- 7.3.6. Analysis by Company Ownership
- 7.3.7. Analysis by Location of Headquarters and Company Ownership
- 7.3.8. Most Active Players: Analysis by Number of Non-Medical Exoskeleton
- 7.3.9. Most Active Players: Analysis by Number of Medical and Non-Medical Exoskeleton

8. MEDICAL EXOSKELETON: PRODUCT COMPETITVENESS ANALYSIS

8.1 Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Medical Exoskeleton: Product Competitiveness Analysis
- 8.4.1. Product Competitiveness Analysis: Upper Body Medical Exoskeleton
  - 8.4.1.1. Product Competitiveness Analysis: Upper Body, Powered Exoskeleton
  - 8.4.1.2. Product Competitiveness Analysis: Upper Body, Passive Exoskeleton
  - 8.4.1.3. Product Competitiveness Analysis: Upper Body, Hybrid Exoskeleton
- 8.4.2. Product Competitiveness Analysis: Lower Body Exoskeleton
  - 8.4.2.1. Product Competitiveness Analysis: Lower Body, Powered Exoskeleton
  - 8.4.2.2. Product Competitiveness Analysis: Lower Body, Passive Exoskeleton
  - 8.4.2.3. Product Competitiveness Analysis: Lower Body, Hybrid Exoskeleton
- 8.4.3. Product Competitiveness Analysis: Full Body Medical Exoskeleton

9. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES

9.1. Chapter Overview
9.2. CYBERDYNE
- 9.2.1. Company Overview
- 9.2.2. Financial Information
- 9.2.3. Product Portfolio
- 9.2.4 Recent Developments and Future Outlook
9.3. Ekso Bionics
- 9.3.1. Company Overview
- 9.3.2. Financial Information
- 9.3.3. Product Portfolio
- 9.3.4 Recent Developments and Future Outlook
9.4. ExoAtlet
- 9.4.1. Company Overview
- 9.4.2. Product Portfolio
- 9.4.3. Recent Developments and Future Outlook
9.5. Fourier Intelligence
- 9.5.1. Company Overview
- 9.5.2. Product Portfolio
- 9.5.3. Recent Developments and Future Outlook
9.6. Gloreha
- 9.6.1. Company Overview
- 9.6.2. Product Portfolio
- 9.6.3. Recent Developments and Future Outlook
9.7. Guangzhou Yikang
- 9.7.1. Company Overview
- 9.7.2. Product Portfolio
- 9.7.3. Recent Developments and Future Outlook
9.8. Hexar Humancare
- 9.8.1. Company Overview
- 9.8.2. Product Portfolio
- 9.8.3. Recent Developments and Future Outlook
9.9. Hocoma
- 9.9.1. Company Overview
- 9.9.2. Product Portfolio
- 9.9.3. Recent Developments and Future Outlook
9.10. Panasonic
- 9.10.1. Company Overview
- 9.10.2. Financial Information
- 9.10.3. Product Portfolio
- 9.10.4. Recent Developments and Future Outlook
9.11. Tyromotion
- 9.11.1. Company Overview
- 9.11.2. Product Portfolio
- 9.11.3. Recent Developments and Future Outlook

10. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES

10.1. Chapter Overview
10.2. Bionic Yantra
10.3. MediTouch
10.4. Milebot Robotics
10.5. Myomo
10.6. Neofect
10.7. NextStep Robotics
10.8. ReWalk Robotics
10.9. Rex Bionics
10.10. Roam Robotics
10.11. Trexo Robotics
10.12. U&O Technologies

11. MEDICAL EXOSKELETON: PARTNERSHIPS AND COLLABORATIONS

11.1. Chapter Overview
11.2. Partnership Models
11.3. Medical Exoskeleton: List of Partnerships and Collaborations
- 11.3.1. Analysis by Year of Partnership
- 11.3.2. Analysis by Type of Partnership
- 11.3.3. Analysis by Year and Type of Partnership
- 11.3.4. Analysis by Type of Partner
- 11.3.5. Analysis by Year of Partnership and Type of Partner
- 11.3.6. Analysis by Purpose of Partnership
- 11.3.7. Analysis by Geography
  - 11.3.7.1. Local and International Agreements
  - 11.3.7.2. Intracontinental and Intercontinental Agreements
  - 11.3.7.3. Most Active Players: Distribution by Number of Partnerships

12. PATENT ANALYSIS

12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Exoskeleton: Patent Analysis
- 12.3.1. Analysis by Patent Application Year
- 12.3.2. Analysis by Patent Publication Year
- 12.3.3. Analysis by Type of Patent and Patent Publication Year
- 12.3.4. Analysis by Publication Time
- 12.3.5. Analysis by Patent Jurisdiction
- 12.3.6. Analysis by CPC symbols
- 12.3.7. Analysis by Type of Applicant
- 12.3.8. Leading Players: Analysis by Number of Patents
- 12.3.9. Leading Patent Assignees: Analysis by Number of Patents
12.4. Exoskeleton: Patent Benchmarking
- 12.4.1. Analysis by Patent Characteristics
- 12.4.2. Exoskeleton: Patent Valuation
12.5. Leading Players by Number of Citations

13. BLUE OCEAN STRATEGY

13.1. Overview of Blue Ocean Strategy
- 13.1.1. Red Oceans
- 13.1.2. Blue Oceans
- 13.1.3. Comparison of Red Ocean Strategy and Blue Ocean Strategy
- 13.1.4. Medical Exoskeleton: Blue Ocean Strategy and Shift Tools
  - 13.1.4.1. Strategy Canvas
  - 13.1.4.2. Pioneer-Migrator-Settler (PMS) Map
  - 13.1.4.3. Buyer Utility Map

14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion

15. GLOBAL EXOSKELETON MARKET

15.1. Chapter Overview
15.2. Forecast Methodology and Key Assumptions
15.3. Global Exoskeleton Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
- 15.3.1. Scenario Analysis
15.4. Key Market Segmentations
15.5. Dynamic Dashboard

16. EXOSKELETON MARKET, BY BODY PART COVERED

16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Medical Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.4. Medical Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.5. Medical Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.6. Non-Medical Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.7. Non-Medical Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.8. Non-Medical Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.9. Overall Upper Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.10. Overall Lower Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.11. Overall Full Body Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.12. Data Triangulation and Validation

17. EXOSKELETON MARKET, BY MODE OF OPERATION

17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. Medical Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.4. Medical Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.5. Medical Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.6. Non-Medical Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.7. Non-Medical Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.8. Non-Medical Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.9. Overall Powered Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.10. Overall Passive Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.11. Overall Hybrid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.12. Data Triangulation and Validation

18. EXOSKELETON MARKET, BY THEIR FORM

18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Medical Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Medical Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.4. Non-Medical Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.5. Non-Medical Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.6. Overall Rigid Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.7. Overall Soft Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.8. Data Triangulation and Validation

19. EXOSKELETON MARKET, BY THEIR MOBILITY

19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Medical Fixed/ Supported Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.4. Medical Mobile / Overground Walking Exoskeleton: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.5. Data Triangulation and Validation

20. EXOSKELETON MARKET, BY END USERS

20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. Medical Exoskeleton by Patients: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4. Medical Exoskeleton by Healthcare Providers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.5. Non-Medical Exoskeleton by Industry Workers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.6. Non-Medical Exoskeleton by Military Personnel: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.7. Non-Medical Exoskeleton by Others: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.8. Overall Exoskeleton by End Users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.9. Data Triangulation and Validation

21. EXOSKELETON MARKET, BY GEOGRAPHY

21.1. Chapter Overview
21.2. Forecast Methodology and Key Assumptions
21.3. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.4. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.5. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.6. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.7. Data Triangulation and Validation

22. CONCLUSION

23. EXECUTIVE INSIGHTS

23.1. Chapter Overview
23.2. ABLE Human Motion
- 23.2.1. Company Snapshot
- 23.2.2. Interview Transcript: Alfons Carnicero Carmona, Co-Founder and Chief Executive Officer
23.3. Archelis
- 23.3.1. Company Snapshot
- 23.3.2. Interview Transcript: Katsuhiko Saho, Director of Business Planning and Development
23.4. Biomotum
- 23.4.1. Company Snapshot
- 23.4.2. Interview Transcript: Phil Astrachan, Vice President of Sales and Marketing
23.5. Bionic Power
- 23.5.1. Company Snapshot
- 23.5.2. Interview Transcript: Rob Nathan, Marketing and Design Manager
23.6. Bionic Yantra
- 23.6.1. Company Snapshot
- 23.6.2. Interview Transcript: Shivakumar Nagarajan, Founder and Director